Cargando…

Circulating soluble CD36 as a novel biomarker for progression and prognosis of HBV-related liver diseases

BACKGROUND: Our previous study suggested CD36 may be a positive regulator of hepatitis B virus (HBV) replication in vitro. Therefore, the present study aimed to investigate whether circulating soluble CD36 (sCD36) could serve as a diagnostic and prognostic biomarker for HBV-related liver diseases ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Chunxian, Xiao, Anhua, Luo, Xiaoqing, Zheng, Enze, Li, Yiyu, Lei, Yu, Zhong, Shan, Chen, Yaxi, Yang, Ping, Tang, Zhurong, Zhou, Zhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667018/ https://www.ncbi.nlm.nih.gov/pubmed/36406414 http://dx.doi.org/10.3389/fmicb.2022.1039614

Ejemplares similares

CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing
por: Zeng, Han, et al.
Publicado: (2021)

CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis
por: Yang, Ping, et al.
Publicado: (2022)

Impact of the interaction between the polymorphisms and hypermethylation of the CD36 gene on a new biomarker of type 2 diabetes mellitus: circulating soluble CD36 (sCD36) in Senegalese females
por: Touré, Maïmouna, et al.
Publicado: (2022)

The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis
por: Luo, Xiaoqing, et al.
Publicado: (2021)

Investigation of the factors associated with circulating soluble CD36 levels in patients with HCV-related chronic liver disease
por: Himoto, Takashi, et al.
Publicado: (2013)

Circulating Soluble CD36 is Similar in Type 1 and Type 2 Diabetes Mellitus versus Non-Diabetic Subjects
por: Castelblanco, Esmeralda, et al.
Publicado: (2019)

The origin of circulating CD36 in type 2 diabetes
por: Alkhatatbeh, M J, et al.
Publicado: (2013)

CD36 Senses Dietary Lipids and Regulates Lipids Homeostasis in the Intestine
por: Zhao, Lei, et al.
Publicado: (2021)

The Circulating Fatty Acid Transporter Soluble CD36 Is Not Associated with Carotid Atherosclerosis in Subjects with Type 1 and Type 2 Diabetes Mellitus
por: Castelblanco, Esmeralda, et al.
Publicado: (2020)

Coronary circulating mononuclear progenitor cells and soluble biomarkers in the cardiovascular prognosis after coronary angioplasty
por: Suárez‐Cuenca, Juan Antonio, et al.
Publicado: (2019)

Circulating CD36 Is Reduced in HNF1A-MODY Carriers
por: Bacon, Siobhan, et al.
Publicado: (2013)

Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular Carcinoma
por: Kumar, Vinod, et al.
Publicado: (2012)

Efficacy and safety of telbivudine treatment for the prevention of HBV perinatal transmission
por: Ren, Cuicui, et al.
Publicado: (2020)

Soluble CD 163: A novel biomarker
por: Ahuja, Rajeev B.
Publicado: (2011)

Relationship between circulating inflammatory factors and glioma risk and prognosis: A meta‐analysis
por: Feng, Yuan, et al.
Publicado: (2019)

Circulating sCD36 is associated with unhealthy fat distribution and elevated circulating triglycerides in morbidly obese individuals
por: Knøsgaard, L, et al.
Publicado: (2014)

Serum potassium levels and prognosis in HBV‐associated decompensated cirrhosis
por: Huang, JianJiang, et al.
Publicado: (2021)

Humanized CD36 (hCD36) mouse model supports the preclinical evaluation of therapeutic candidates targeting CD36
por: Xie, Xiulong, et al.
Publicado: (2023)

CD36 regulates diurnal glucose metabolism and hepatic clock to maintain glucose homeostasis in mice
por: Chen, Mengyue, et al.
Publicado: (2023)

CD163 as a Biomarker in Colorectal Cancer: The Expression on Circulating Monocytes and Tumor-Associated Macrophages, and the Soluble Form in the Blood
por: Krijgsman, Daniëlle, et al.
Publicado: (2020)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

Circulating Soluble CD163: A Potential Predictor for the Functional Outcome of Acute Ischemic Stroke
por: Sun, Houchao, et al.
Publicado: (2021)

Circulating Interferon-λ3, Responsiveness to HBV Vaccination, and HBV/HCV Infections in Haemodialysis Patients
por: Grzegorzewska, Alicja E., et al.
Publicado: (2017)

Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress
por: Liu, Jun, et al.
Publicado: (2018)

Inflammatory Stress Increases Hepatic CD36 Translational Efficiency via Activation of the mTOR Signalling Pathway
por: Wang, Chuan, et al.
Publicado: (2014)

Down-expression of CD36 in pancreatic adenocarcinoma and its correlation with clinicopathological features and prognosis
por: Jia, Shengnan, et al.
Publicado: (2018)

Surface-exposed and soluble calreticulin: conflicting biomarkers for cancer prognosis
por: Kepp, Oliver, et al.
Publicado: (2020)

Plasma soluble CD36, carotid intima-media thickness and cognitive function in patients with type 2 diabetes
por: Jiang, Xiaozhen, et al.
Publicado: (2016)

Circulating Neutrophil Dysfunction in HBV-Related Acute-on-Chronic Liver Failure
por: Wu, Wei, et al.
Publicado: (2021)

Circulating tumor cells as a potential biomarker for postoperative clinical outcome in HBV-related hepatocellular carcinoma
por: Ye, Xinping, et al.
Publicado: (2018)

Circulating CD36 and oxLDL levels are associated with cardiovascular risk factors in young subjects
por: Ramos-Arellano, Luz E, et al.
Publicado: (2014)

Association of CD44 polymorphisms and susceptibility to HBV‐related hepatocellular carcinoma in the Chinese population
por: Deng, Yan, et al.
Publicado: (2019)

Potentials of the elevated circulating miR-185 level as a biomarker for early diagnosis of HBV-related liver fibrosis
por: Li, Bin-bin, et al.
Publicado: (2016)

Increased Soluble CD137 Levels and CD4+ T‐Cell‐Associated Expression of CD137 in Acute Atherothrombotic Stroke
por: He, Yang, et al.
Publicado: (2018)

Soluble CD93 as a Novel Biomarker in Asthma Exacerbation
por: Sigari, Naseh, et al.
Publicado: (2016)

Soluble CD163 as a Potential Biomarker in Systemic Sclerosis
por: Frantz, Camelia, et al.
Publicado: (2018)

Soluble CD163 in intracerebral hemorrhage: biomarker for perihematomal edema
por: Roy‐O'Reilly, Meaghan, et al.
Publicado: (2017)

Soluble CD36 Ectodomain Binds Negatively Charged Diacylglycerol Ligands and Acts as a Co-Receptor for TLR2
por: Jimenez-Dalmaroni, Maximiliano J., et al.
Publicado: (2009)

Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies
por: Glez-Vaz, Javier, et al.
Publicado: (2022)

Obesity induces preadipocyte CD36 expression promoting inflammation via the disruption of lysosomal calcium homeostasis and lysosome function
por: Luo, Xiaoxiao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i5m5c899tau7vlagcgm4lqp25h